- Home
- CPAY vs PODD Comparison
CPAY vs PODD Comparison
Compare CPAY & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAY
- PODD
- Stock Information
- Founded
- CPAY 1986
- PODD 2000
- Country
- CPAY United States
- PODD United States
- Employees
- CPAY N/A
- PODD N/A
- Industry
- CPAY EDP Services
- PODD Medical/Dental Instruments
- Sector
- CPAY Technology
- PODD Health Care
- Exchange
- CPAY Nasdaq
- PODD Nasdaq
- Market Cap
- CPAY 22.2B
- PODD 23.8B
- IPO Year
- CPAY 2010
- PODD 2007
- Fundamental
- Price
- CPAY $310.75
- PODD $322.22
- Analyst Decision
- CPAY Buy
- PODD Strong Buy
- Analyst Count
- CPAY 13
- PODD 18
- Target Price
- CPAY $394.33
- PODD $334.50
- AVG Volume (30 Days)
- CPAY 352.5K
- PODD 568.2K
- Earning Date
- CPAY 11-06-2025
- PODD 11-06-2025
- Dividend Yield
- CPAY N/A
- PODD N/A
- EPS Growth
- CPAY 6.87
- PODD N/A
- EPS
- CPAY 14.72
- PODD 3.32
- Revenue
- CPAY $4,171,325,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- CPAY $14.00
- PODD $29.18
- Revenue Next Year
- CPAY $10.51
- PODD $18.09
- P/E Ratio
- CPAY $21.10
- PODD $96.84
- Revenue Growth
- CPAY 9.22
- PODD 26.00
- 52 Week Low
- CPAY $269.02
- PODD $225.37
- 52 Week High
- CPAY $400.81
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- CPAY 45.46
- PODD 43.19
- Support Level
- CPAY $302.39
- PODD $336.00
- Resistance Level
- CPAY $314.42
- PODD $351.94
- Average True Range (ATR)
- CPAY 6.99
- PODD 10.05
- MACD
- CPAY -0.89
- PODD -3.32
- Stochastic Oscillator
- CPAY 33.39
- PODD 22.31
About CPAY Corpay Inc.
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.